Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Review Articles

Early Access

Strength, challenges and potential solutions for the advancement of the research ecosystem in AYUSH: Insights derived from the COVID-19 pandemic

DOI
https://doi.org/10.14719/pst.3780
Submitted
27 April 2024
Published
02-04-2025
Versions

Abstract

The Ministry of Ayush (MoA), either independently or in collaboration, has diligently endeavoured to ascertain the significance of India's Ayush system in mitigating and managing COVID-19 pandemics since its inception. Despite the various constraints posed by limited resources and other impediments, a substantial amount of research has been undertaken in the Ayush arena, as evidenced by the considerable number of clinical trials registered in the Clinical Trial Registry of India (CTRI) and further on the several medical databases. To summarise the clinical trials of Ayush interventions against COVID-19, a living systematic review and meta-analysis were conducted at ITRA, Jamnagar in collaboration with South-East Asia Regional Office of World Health Organisation (WHO SEARO), New Delhi. During the course of this process, several research gaps and challenges have been observed. Researchers observed that many studies lacked in quality owning to design, execution or analysis level. There is a huge need for the upliftment of the research environment in the Ayush system of Medicines. This article has highlighted the gaps in the scientific literature, its impact on evidence quality and the feasible and practical solutions to rectify those. Continuous capacity-building to human resources, incorporation of a whole system approach in research design without breaking integrity and validity and adherence to standard international guidelines in protocol designing and reporting are a few of the propositions for future endeavours. The analysis of these issues is crucial for the prospective development of research in the field of traditional medicine.

References

  1. World Health Organization. WHO Coronavirus disease (COVID-19) dashboard [Internet]. [cited 2022 Jan 18] Available from: https://www.who.int/data
  2. Zimmermann LV, Salvatore M, Babu GR, Mukherjee B. Estimating COVID-19? related mortality in India: An epidemiological challenge with insufficient data. American Journal of Public Health. 2021;111(S2):S59–62. https://doi.org/10.2105/AJPH.2021.306419
  3. Pneumonia in China, 2019. The New England Journal of Medicine. 2020;382(8):727–33. https://doi.org/10.1056/NEJMoa2001017
  4. Parodi SM, Liu VX. From containment to mitigation of COVID-19 in the US. JAMA. 2020;323(15):1441–2. https://doi.org/10.1001/jama.2020.3882
  5. Sadeghmoghadam L, Daneshfar M, Sharifi F, Alizad V. How the first cases of COVID-19 in 10 countries become infected? a case series. Respiratory Medicine Case Reports. 2020;16(46):101219. https://doi.org/10.1016/j.rmcr.2020.101219
  6. World Health Organisation. Archived: WHO timeline - COVID-19 [Internet]. [cited: 2020 Oct 27] https://www.who.int/news/item/27-04-2020-who-timeline---covid-19
  7. Chavda VP, Vihol DR, Solanki HK, Apostolopoulos V. The vaccine world of COVID-19: India's contribution. Vaccines (Basel). 2022;10(11):1943. https://doi.org/10.3390/vaccines10111943
  8. India. Ministry of Ayush. Health [Internet]. [cited 2023 Jan 1]. Available from: https://ayush.gov.in/alldomains.html
  9. India. Ministry of AYUSH. Home care guidelines and advisory for Ayush practitioners about prophylactic care in children [Internet]. [cited 2020 May 17] Available from: https://main.ayush.gov.in/home-care-guidelines-for-children-and-advisory-for-ayush-practitioners-about-prophylactic-in-children-during-the-covid-19-pandemic/
  10. India. Ministry of AYUSH. Guidelines for Ayush practitioners for COVID-19 [Internet]. [cited 2020 May 25]. Available from: https://www.ayush.gov.in/ayush-guidelines.html
  11. NITI Aayog. Mitigation and management of COVID-19 [Internet]. [Cited on 2022 Jun 29]. Available from: https://www.niti.gov.in/sites/default/files/2022-07/COMPENDIUM-OF-AYUSH-BASED-PRACTICES_29-06-2022%281%29.pdf
  12. Thakar A, Goyal M, Bhinde S, Chhotala Y, Panara K, Chaudhari S. Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study. Journal of Ayurveda and Integrative Medicine [Internet]. 2022;13(3):100587. https://doi/10.1016/j.jaim.2022.100587
  13. Godatwar PK, Deshpande S, Joshi Deshmukh PS, Deshpande VS, Ghungralekar R, Tamoli S, et al. Clinical evaluation of Chyawanprash as a preventive measure during the COVID-19 pandemic: an open-label, multicentric, randomized, comparative, prospective, and interventional community-based clinical study on healthy individuals. Journal of Indian System of Medicine. 2021;9(2):104. https://doi.org/10.4103/jism.jism_27_21
  14. Thakar A, Panara K, Shah H, Kalsariya B, Ruparel S, Jain N, et al. Guduchi Ghanavati (Ayurveda medication) improves the perceived immunity in individuals at risk of SARS-CoV-2: A multicentred, controlled, before-and-after study. European Journal of Integrative Medicine. 2022;53:102131. https://doi.org/10.1016/j.eujim.2022.102131
  15. Chopra A, Rao PK, Reddy G, Gundeti M, Choudhary K, Lakdawala M, et al. A safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19 in high-risk health-care workers: A randomized controlled, non-inferiority trial. OSF preprint. 2021. https://doi.org/10.31219/osf.io/s3v6k
  16. Mukherjee SK, Ganguly S, Das S, Chatterjee KK, Naskar KK, Dey S, et al. Homeopathic medicines used as prophylaxis in Kolkata during the COVID-19 pandemic: A community-based, cluster-randomized trial. Homeopathy. 2022;111(2):97–104. https://doi.org/10.1055/s-0041-1734026
  17. Ramya JE, Chandran GS, Alagesan S, Victoria S, Devi M, Antony S, et al. A prospective observational study of the outcome of treatment with Kabasura Kudineer among patients with SARS-nCOV-2 infection. International Journal of Nutrition Pharmacology Neurological Diseases. 2021;11(2):169. https://doi.org/10.4103/ijnpnd.ijnpnd_113_20
  18. Srivastava A, Rengaraju M, Srivastava S, Narayanan V, Gupta V, Upadhayay R, et al. Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial. Trials. 2021;28;22(1):570. https://doi.org/10.1186/s13063-021-05478-0
  19. Thakar A, Panara K, Goyal M, Kumari R, Sungchol K. AYUSH (Indian System of Medicines) therapeutics for COVID-19: A living systematic review and meta-analysis (First update). Journal of Integrative and Complementary Medicine. 2023;29(3):139–55. https://doi.org/10.1089/jicm.2022.0559
  20. Thakar A, Panara K, Goyal M, Kumari R, Sungchol K. Impact of AYUSH interventions on COVID-19: a protocol for a living systematic review and meta-analysis. F1000 Research. 2021;28(10):674. https://doi.org/10.12688/f1000research.55109.2
  21. Ayush research portal, evidence-based research data of AYUSH systems at global level, Ministry of AYUSH, Government of India. Research and Development Initiatives of Ministry of Ayush for COVID-19 [Cited on 2023 Jul 24]. Available from: https://ayushportal.nic.in/pdf/Research_and_Development_Initiatives_of_Ministry_of_Ayush_for_COVID-19.pdf
  22. India. Ministry of AYUSH. Formal launch of the inter-disciplinary studies involving AYUSH interventions for COVID 19 situation [Cited 2021 May 20]. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1621492
  23. Ayush research portal, evidence-based research data of AYUSH systems at global level, Ministry of AYUSH, Government of India. National Repository on AYUSH COVID-19 Clinical and Other R&D Initiatives. COVID-19 related AYUSH Research & Development Articles [Accessed 2023 Oct. 22]. Available from: https://ayushportal.nic.in/Covid.aspx
  24. Seligman WH, Fialho L, Sillett N, Nielsen C, Baloch FM, Collis P, Demedts IKM, et al. Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working Group. BMJ Open. 2021;11(11):e051065. https://doi.org/10.1136/bmjopen-2021-051065
  25. Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials. BJOG. 2018;125(13):1716. https://doi.org/10.1111/1471-0528.15199
  26. The COVID-NMA initiative living mapping and living systematic review of Covid-19 trials. COVID-19 treatments. [Updated 2023 Aug 02, Accessed 2024 Jan 28] Available from: https://covid-nma.com/dataviz/
  27. Ayush research portal. Compendium of select research publications on Ayush Interventios for COVID-19 (24/07/2023). Evidence based Ayush interventions for COVID-19, Compendium of select Research Publication [Cited on 2023 Jul 24]. Available from: https://ayushportal.nic.in/pdf/Compendium_of_select_research_publications_on_the_Ayush_Interventions_for_COVID-19.pdf
  28. Ye L, Fan S, Zhao P, Wu C, Liu M, Hu S, et al. Potential herb?drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. Acta Pharmaceutica Sinica B. 2023;5;13(9):3598–637. https://doi.org/10.1016/j.apsb.2023.06.001
  29. Fandino W. Formulating a good research question: Pearls and pitfalls. Indian Journal of Anaesthesia. 2019;63(8):611–6. https://doi.org/10.4103/ija.IJA_198_19
  30. Wang X, Ji X. Sample size estimation in clinical research: From randomized controlled trials to observational studies. Chest. 2020;158(1S):S12–20. https://doi.org/10.1016/j.chest.2020.03.010
  31. Equator Network, Enhancing the QUAlity and Transparency Of health Research [Accessed on 2023 Oct 26]. Available from: https://www.equator-network.org/
  32. Equator Network, Enhancing the QUAlity and Transparency Of health Research. The PRISMA2020 statement: An updated guideline for reporting systematic reviews [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/prisma/
  33. Equator Network, Enhancing the QUAlity and Transparency Of health Research. Preferred Reporting Items for Systematic Review and Meta - Analysis Protocols (PRISMA-P) 2015 statement [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/prisma-protocols/
  34. Equator Network, Enhancing the QUAlity and Transparency Of health Research. CONSORT2010 Statement: updated guidelines for reporting parallel group randomised trials [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/consort/
  35. Equator Network, Enhancing the QUAlity and Transparency Of health Research. SPIRIT2013 Statement: Defining standard protocol items for clinical trials [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/
  36. Equator Network, Enhancing the QUAlity and Transparency Of health Research. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/strobe/
  37. Equator Network, Enhancing the QUAlity and Transparency Of health Research. STARD2015: An updated list of essential items for reporting diagnostic accuracy studies [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/stard/
  38. Equator Network, Enhancing the QUAlity and Transparency Of health Research. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/tripod-statement/
  39. Equator Network, Enhancing the QUAlity and Transparency Of health Research. The CARE Guidelines: Consensus-based clinical case reporting guideline development [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/care/
  40. Equator Network, Enhancing the QUAlity and Transparency Of health Research. The ARRIVE Guidelines 2.0: updated guidelines for reporting animal research [Accessed 2023 Oct. 26]. Available from: https://www.equator-network.org/reporting-guidelines/improving-bioscience-research-reporting-the-arrive-guidelines-for-reporting-animal-research/
  41. Gautama PA. RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities. Journal of Ayurveda and Integrative Medicine. 2021;12(3):556–61. https://doi.org/10.1016/j.jaim.2021.06.012
  42. Furst DE, Venkatraman MM, McGann M, Manohar PR, Booth-LaForce C, Sarin R, Sekar PG, et al. Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. Journal of Clinical Rheumatology. 2011;17(4):185–92. https://doi.org/10.1097/RHU.0b013e31821c0310
  43. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology. 2008;4(11):682–90. https://doi.org/10.1038/nchembio.118
  44. Amiteye S. Basic concepts and methodologies of DNA marker systems in plant molecular breeding. Heliyon. 2021;30;7(10):e08093. https://doi.org/10.1016/j.heliyon.2021.e08093
  45. Trainer’s manual on good agricultural and collection practices (GACP) for medicinal plants [Accessed 2023 Oct. 26]. Available from: https://dmapr.icar.gov.in/Downloads/Trainersmanual.pdf
  46. World Health Organisation. Health products policy and standards. [Accessed 2023 Oct. 26] Available from: https://www.who.int/teams/health-product-and-policy-standards/standards-and-specifications/norms-and-standards-for-pharmaceuticals/guidelines/production
  47. GRADEpro. GRADEpro GDT: GRADEpro Guideline Development Tool [Software] [Accessed 2023 Jun. 26] . McMaster University, 2020 (developed by Evidence Prime, Inc.). Available from: gradepro.org
  48. Schu¨nemann H, Brozek J, Guyatt G, et al, (eds). GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group; 2013 [Accessed 2023 Jun. 26]. Available from: guidelinedevelopment.org/handbook

Downloads

Download data is not yet available.